UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia

Acta psychiatrica Scandinavica, 2014-10, Vol.130 (4), p.290-299

2014

Volltextzugriff (PDF)

Impact of primary negative symptoms on functional outcomes in schizophrenia

European psychiatry, 2014-09, Vol.29 (7), p.449-455

2014

Volltextzugriff (PDF)

Prediction of longitudinal functional outcomes in schizophrenia: The impact of baseline motivational deficits

Schizophrenia research, 2011-10, Vol.132 (1), p.24-27

2011

Volltextzugriff (PDF)

Motivated to do well: An examination of the relationships between motivation, effort, and cognitive performance in schizophrenia

Schizophrenia research, 2015-08, Vol.166 (1), p.276-282

2015

Volltextzugriff (PDF)

Clozapine administration in clinical practice: once-daily versus divided dosing

Acta psychiatrica Scandinavica, 2016-09, Vol.134 (3), p.234-240

2016

Volltextzugriff (PDF)

Environment and vulnerability to major psychiatric illness : a case control study of early parental loss in major depression, bipolar disorder and schizophrenia

Molecular psychiatry, 1999-03, Vol.4 (2), p.163-172

1999

Volltextzugriff (PDF)

The impact of parental death versus separation from parents on the mental health of Israeli adolescents

Comprehensive psychiatry, 2000-09, Vol.41 (5), p.360-368

2000

Volltextzugriff (PDF)

Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder

The journal of clinical psychiatry, 2001-03, Vol.62 (3), p.169-173

2001

Volltextzugriff (PDF)

Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders

Schizophrenia research, 2008-07, Vol.102 (1), p.241-248

2008

Volltextzugriff (PDF)

Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trial

Journal of clinical psychopharmacology, 2012-02, Vol.32 (1), p.95-99

2012

Volltextzugriff (PDF)

Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation

The international journal of neuropsychopharmacology, 2003-03, Vol.6 (1), p.41-49, Article S146114570200322X

2003

Volltextzugriff (PDF)

Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected

Archives of general psychiatry, 2003-12, Vol.60 (12), p.1228

2003

Volltextzugriff (PDF)

Increased prevalence of negative life events in subtypes of major depressive disorder

Comprehensive psychiatry, 2001, Vol.42 (1), p.57-63

2001

Volltextzugriff (PDF)

Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized Dystonia

The New England journal of medicine, 2005-02, Vol.352 (5), p.459-467

2005

Volltextzugriff (PDF)

Meta-Regression Analysis of Placebo Response in Antipsychotic Trials, 1970–2010

The American journal of psychiatry, 2013-11, Vol.170 (11), p.1335-1344

2013

Volltextzugriff (PDF)

G51D α-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome

Annals of neurology, 2013-04, Vol.73 (4), p.459-471

2013

Volltextzugriff (PDF)

Neurostimulation for Parkinson's Disease with Early Motor Complications

The New England journal of medicine, 2013-02, Vol.368 (7), p.610-622

2013

Volltextzugriff (PDF)

Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease

Human molecular genetics, 2011, Vol.20 (1), p.202-210

2011

Volltextzugriff (PDF)

Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population

Human molecular genetics, 2011-02, Vol.20 (3), p.615-627

2011

Volltextzugriff (PDF)

Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: Concept and standards of the EARLYSTIM-study

Parkinsonism & related disorders, 2013-01, Vol.19 (1), p.56-61

2013

Volltextzugriff (PDF)

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial

Lancet neurology, 2018-03, Vol.17 (3), p.223-231

2018

Volltextzugriff (PDF)

Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease

Brain (London, England : 1878), 2009-01, Vol.132 (1), p.172-184

2009

Volltextzugriff (PDF)

Subthalamic Nucleus Stimulation in Severe Obsessive–Compulsive Disorder

The New England journal of medicine, 2008-11, Vol.359 (20), p.2121-2134

2008

Volltextzugriff (PDF)

Measuring the effects of treatment with antipsychotics

JAMA psychiatry (Chicago, Ill.), 2015-05, Vol.72 (5), p.514

2015

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(82)

Sprache

Englisch
(81)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia

Impact of primary negative symptoms on functional outcomes in schizophrenia

Prediction of longitudinal functional outcomes in schizophrenia: The impact of baseline motivational deficits

Motivated to do well: An examination of the relationships between motivation, effort, and cognitive performance in schizophrenia

Clozapine administration in clinical practice: once-daily versus divided dosing

Environment and vulnerability to major psychiatric illness : a case control study of early parental loss in major depression, bipolar disorder and schizophrenia

The impact of parental death versus separation from parents on the mental health of Israeli adolescents

Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder

Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders

Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trial

Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation

Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected

Increased prevalence of negative life events in subtypes of major depressive disorder

Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized Dystonia

Meta-Regression Analysis of Placebo Response in Antipsychotic Trials, 1970–2010

G51D α-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome

Neurostimulation for Parkinson's Disease with Early Motor Complications

Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease

Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population

Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: Concept and standards of the EARLYSTIM-study

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial

Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease

Subthalamic Nucleus Stimulation in Severe Obsessive–Compulsive Disorder

Measuring the effects of treatment with antipsychotics

Phenotype, genotype, and worldwide genetic penetrance of LRRK2 -associated Parkinson's disease: a case-control study

Aktive Filter

Suchergebnisse filtern